Skip to content
2000
Volume 6, Issue 3
  • ISSN: 1568-0266
  • E-ISSN: 1873-4294

Abstract

Modulation of the androgen receptor has the potential to be an effective treatment for hypogonadism, andropause, and associated conditions such as sarcopenia, osteoporosis, benign prostatic hyperplasia, and sexual dysfunction. Side effects associated with classical anabolic steroid treatments have driven the quest for drugs that demonstrate improved therapeutic profiles. Novel, non-steroidal compounds that show tissue selective activity and improved pharmacokinetic properties have been developed. This review provides an overview of current advances in the development of selective androgen receptor modulators (SARMs).

Loading

Article metrics loading...

/content/journals/ctmc/10.2174/156802606776173456
2006-02-01
2025-09-27
Loading full text...

Full text loading...

/content/journals/ctmc/10.2174/156802606776173456
Loading

  • Article Type:
    Research Article
Keyword(s): AR; dihydrotestosterone; estradiol; hypogonadism; modulation; SARMs; testosterone; tissue selectivity
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test